Author： Taneja Charu Juday Timothy Gertzog Larry Edelsberg John Correll Todd Hebden Tony Oster Gerry
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.15, 2012-10, pp. : 2111-2118
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Emerging Roles of Non-Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Therapy
By Moyle G.
Drugs, Vol. 61, Iss. 1, 2001-01 ,pp. :
Access to resources
Recommend
Non-nucleoside inhibitors of HIV-1 reverse transcriptase
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. :
Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase Inhibitors
By Smith P.F.
Clinical Pharmacokinetics, Vol. 40, Iss. 12, 2001-01 ,pp. :
HIV-1 non-nucleoside reverse transcriptase inhibitors
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. :